BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12684155)

  • 1. Progesterone receptor isoform B in the human fallopian tube and endometrium following mifepristone.
    Sun X; Christow A; Marions L; Gemzell-Danielsson K
    Contraception; 2003 Apr; 67(4):319-26. PubMed ID: 12684155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mifepristone on endometrial receptivity.
    Danielsson KG; Marions L; Bygdeman M
    Steroids; 2003 Nov; 68(10-13):1069-75. PubMed ID: 14668000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukaemia inhibitory factor receptor and gp130 in the human Fallopian tube and endometrium before and after mifepristone treatment and in the human preimplantation embryo.
    Wånggren K; Lalitkumar PG; Hambiliki F; Ståbi B; Gemzell-Danielsson K; Stavreus-Evers A
    Mol Hum Reprod; 2007 Jun; 13(6):391-7. PubMed ID: 17430984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of heparin-binding epidermal growth factor-like growth factor and its receptors in the human fallopian tube and endometrium after treatment with mifepristone.
    Sun XX; Gemzell-Danielsson K; Li HZ; Stâbi B; Stavreus-Evers A
    Fertil Steril; 2006 Jan; 85(1):171-8. PubMed ID: 16412750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of mifepristone and levonorgestrel on expression of steroid receptors in the human Fallopian tube.
    Christow A; Sun X; Gemzell-Danielsson K
    Mol Hum Reprod; 2002 Apr; 8(4):333-40. PubMed ID: 11912281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mifepristone on the expression of cytokines in the human Fallopian tube.
    Li HZ; Sun X; Stavreus-Evers A; Gemzell-Danielsson K
    Mol Hum Reprod; 2004 Jul; 10(7):489-93. PubMed ID: 15121876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2 and F2alpha receptors in the human Fallopian tube before and after mifepristone treatment.
    Wånggren K; Lalitkumar PG; Stavreus-Evers A; Ståbi B; Gemzell-Danielsson K
    Mol Hum Reprod; 2006 Sep; 12(9):577-85. PubMed ID: 16820403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
    Gemzell-Danielsson K; Swahn ML; Svalander P; Bygdeman M
    Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of an antiprogesterone up-regulates estrogen receptors in the endometrium of women using Norplant: a pilot study.
    Glasier AF; Wang H; Davie JE; Kelly RW; Critchley HO
    Fertil Steril; 2002 Feb; 77(2):366-72. PubMed ID: 11821099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a single post-ovulatory dose of RU486 on endometrial maturation in the implantation phase.
    Gemzell-Danielsson K; Svalander P; Swahn ML; Johannisson E; Bygdeman M
    Hum Reprod; 1994 Dec; 9(12):2398-404. PubMed ID: 7714164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of mifepristone on the expression of insulin-like growth factor binding protein-1, prolactin and progesterone receptor mRNA and protein during the implantation phase in human endometrium.
    Qiu X; Sun X; Christow A; Ståbi B; Gemzell-Danielsson K
    Mol Hum Reprod; 2002 Nov; 8(11):998-1004. PubMed ID: 12397212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of mifepristone on the transcriptomic signature of endometrial receptivity.
    von Grothusen C; Lalitkumar PG; Ruiz-Alonso M; Boggavarapu NR; Navarro R; Miravet-Valenciano J; Gemzell-Danielsson K; Simon C
    Hum Reprod; 2018 Oct; 33(10):1889-1897. PubMed ID: 30137464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ulipristal acetate resembles mifepristone in modulating human fallopian tube function.
    Li HW; Liao SB; Yeung WS; Ng EH; O WS; Ho PC
    Hum Reprod; 2014 Oct; 29(10):2156-62. PubMed ID: 25139173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of antiprogestin on integrin expression in human endometrium: an immunohistochemical study.
    Marions L; Gemzell Danielsson K; Bygdeman M
    Mol Hum Reprod; 1998 May; 4(5):491-5. PubMed ID: 9665636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation.
    Cameron ST; Critchley HO; Buckley CH; Kelly RW; Baird DT
    Fertil Steril; 1997 Jun; 67(6):1046-53. PubMed ID: 9176442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contraceptive use of antiprogestin.
    Bygdeman M; Danielsson KG; Marions L; Swahn ML
    Eur J Contracept Reprod Health Care; 1999 Jun; 4(2):103-7. PubMed ID: 10427485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The possible use of antiprogestins for contraception.
    Bygdeman M; Danielsson KG; Swahn ML
    Acta Obstet Gynecol Scand Suppl; 1997; 164():75-7. PubMed ID: 9225644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long-term low-dose mifepristone on reproductive function in women.
    Croxatto HB; Kovács L; Massai R; Resch BA; Fuentealba B; Salvatierra AM; Croxatto HD; Zalányi S; Viski S; Krenács L
    Hum Reprod; 1998 Apr; 13(4):793-8. PubMed ID: 9619526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mifepristone on uterine receptivity in guinea pigs.
    Liu CQ; Wang ZX; Yuan Y
    Acta Pharmacol Sin; 2002 Feb; 23(2):177-82. PubMed ID: 11866881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of progesterone antagonists and progesterone receptor modulators in contraception.
    Spitz IM; Van Look PF; Coelingh Bennink HJ
    Steroids; 2000; 65(10-11):817-23. PubMed ID: 11108893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.